Human orexin/hypocretin receptors form constitutive homo- and heteromeric complexes with each other and with human CB1 cannabinoid receptors

Biochemical and Biophysical Research Communications

Volumn 445, Issue 2, 2014, Pages 486-490

  Jäntti, Maria H ^a   Mandrika, Ilona ^b   Kukkonen, Jyrki P ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b LATVIAN BIOMEDICAL RESEARCH AND STUDY CENTRE   (Latvia)

Author keywords

Bioluminescence resonance energy transfer; Cannabinoid; dimerization; G protein coupled receptor; Hypocretin; Orexin

Indexed keywords

CANNABINOID 1 RECEPTOR; ENDOCANNABINOID; GREEN FLUORESCENT PROTEIN; HYBRID PROTEIN; OREXIN 1 RECEPTOR; OREXIN 2 RECEPTOR; OREXIN RECEPTOR; RENILLA LUCIFERIN 2 MONOOXYGENASE;

ANIMAL CELL; ARTICLE; BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CARBOXY TERMINAL SEQUENCE; CHO CELL; COMPLEX FORMATION; CONTROLLED STUDY; DIMERIZATION; GENETIC TRANSFECTION; GEOMETRY; HETEROMERIC COMPLEX; HOMOMERIC COMPLEX; HUMAN; NONHUMAN; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; TRANSIENT EXPRESSION;

CRICETULUS GRISEUS; RENILLA LUCIFERASE;

BIOLUMINESCENCE RESONANCE ENERGY TRANSFER; CANNABINOID; DIMERIZATION; G-PROTEIN-COUPLED RECEPTOR; HYPOCRETIN; OREXIN;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HUMANS; LUMINESCENT MEASUREMENTS; OREXIN RECEPTORS; PROTEIN MULTIMERIZATION; RECEPTOR, CANNABINOID, CB1; RECOMBINANT FUSION PROTEINS;

EID: 84896082268     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2014.02.026     Document Type: Article

References (34)

1. J.P. Pin, J. Kniazeff, J. Liu, V. Binet, C. Goudet, P. Rondard, and L. Prezeau Allosteric functioning of dimeric class C G-protein-coupled receptors FEBS J. 272 2005 2947 2955 (Pubitemid 40904683)
2. D. Maurel, L. Comps-Agrar, C. Brock, M.L. Rives, E. Bourrier, M.A. Ayoub, H. Bazin, N. Tinel, T. Durroux, L. Prezeau, E. Trinquet, and J.P. Pin Cell-surface protein-protein interaction analysis with time-resolved FRET and snap-tag technologies: application to GPCR oligomerization Nat. Methods 5 2008 561 567 (Pubitemid 351761765)
3. 1 cannabinoid receptors as an example Chem. Phys. Lipids 121 2002 83 89 (Pubitemid 36044545)
4. 1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor cross-talk? Mol. Pharmacol. 67 2005 1697 1704 (Pubitemid 40594170)
5. J.A. Hern, A.H. Baig, G.I. Mashanov, B. Birdsall, J.E. Corrie, S. Lazareno, J.E. Molloy, and N.J. Birdsall Formation and dissociation of M1 muscarinic receptor dimers seen by total internal reflection fluorescence imaging of single molecules Proc. Natl. Acad. Sci. U S A 107 2010 2693 2698
6. C. Hague, M.A. Uberti, Z. Chen, R.A. Hall, and K.P. Minneman Cell surface expression of alpha1D-adrenergic receptors is controlled by heterodimerization with alpha1B-adrenergic receptors J. Biol. Chem. 279 2004 15541 15549 (Pubitemid 38618955)
7. S.C. Prinster, T.G. Holmqvist, and R.A. Hall Alpha2C-adrenergic receptors exhibit enhanced surface expression and signaling upon association with beta2-adrenergic receptors J. Pharmacol. Exp. Ther. 318 2006 974 981 (Pubitemid 44268302)
8. B.A. Jordan, and L.A. Devi G-protein-coupled receptor heterodimerization modulates receptor function Nature 399 1999 697 700 (Pubitemid 29289066)
9. I. Gomes, B.A. Jordan, A. Gupta, N. Trapaidze, V. Nagy, and L.A. Devi Heterodimerization of mu and delta opioid receptors: A role in opiate synergy J. Neurosci. 20 2000 RC110
10. C. Hipser, I. Bushlin, A. Gupta, I. Gomes, and L.A. Devi Role of antibodies in developing drugs that target G-protein-coupled receptor dimers Mt. Sinai J. Med. 77 2010 374 380
11. C. Hiller, J. Kuhhorn, and P. Gmeiner Class A G-protein-coupled receptor (GPCR) dimers and bivalent ligands J. Med. Chem. 56 2013 6542 6559
12. J.P. Kukkonen Physiology of the orexinergic/hypocretinergic system: a revisit in 2012 Am. J. Physiol. Cell Physiol. 301 2013 C2 C32
13. J. Li, Z. Hu, and L. de Lecea The hypocretins/orexins: integrators of multiple physiological functions Br. J. Pharmacol. 171 2014 332 350
14. J.P. Kukkonen, and C.S. Leonard Orexin/hypocretin receptor signalling cascades Br. J. Pharmacol. 171 2014 294 313
15. C.S. Leonard, and J.P. Kukkonen Orexin/hypocretin receptor signalling: a functional perspective Br. J. Pharmacol. 171 2014 294 313
16. C.J. Winrow, and J.J. Renger Discovery and development of orexin receptor antagonists as therapeutics for insomnia Br. J. Pharmacol. 171 2014 283 293
17. M. Kano, T. Ohno-Shosaku, Y. Hashimotodani, M. Uchigashima, and M. Watanabe Endocannabinoid-mediated control of synaptic transmission Physiol. Rev. 89 2009 309 380
18. S. Haj-Dahmane, and R.Y. Shen The wake-promoting peptide orexin-B inhibits glutamatergic transmission to dorsal raphe nucleus serotonin neurons through retrograde endocannabinoid signaling J. Neurosci. 25 2005 896 905 (Pubitemid 40171005)
19. Y.C. Ho, H.J. Lee, L.W. Tung, Y.Y. Liao, S.Y. Fu, S.F. Teng, H.T. Liao, K. Mackie, and L.C. Chiou Activation of orexin 1 receptors in the periaqueductal gray of male rats leads to antinociception via retrograde endocannabinoid (2-arachidonoylglycerol)-induced disinhibition J. Neurosci. 31 2011 14600 14610
20. P.M. Turunen, M.H. Jäntti, and J.P. Kukkonen OX1 orexin/hypocretin receptor signaling via arachidonic acid and endocannabinoid release Mol. Pharmacol. 82 2012 156 167
21. 1 cannabinoid-OX1 orexin receptor coexpression Mol. Pharmacol. 83 2013 621 632
22. 1 receptor and the orexin OX1 receptor generates a unique complex in which both protomers are regulated by orexin A J. Biol. Chem. 286 2011 37414 37428
23. T.R. Xu, R.J. Ward, J.D. Pediani, and G. Milligan The orexin OX1 receptor exists predominantly as a homodimer in the basal state: potential regulation of receptor organization by both agonist and antagonist ligands Biochem. J. 439 2011 171 183
24. J. Putula, P.M. Turunen, L. Johansson, J. Näsman, R. Ra, L. Korhonen, and J.P. Kukkonen Orexin/hypocretin receptor chimaeras reveal structural features important for orexin peptide distinction FEBS Lett. 585 2011 1368 1374
25. 1 T210 produce active and inactive receptor forms: correlations with ligand affinity, receptor stability, and cellular localization Biochemistry 45 2006 5606 5617 (Pubitemid 43673191)
26. I. Mandrika, R. Petrovska, and J. Klovins Evidence for constitutive dimerization of niacin receptor subtypes Biochem. Biophys. Res. Commun. 395 2010 281 287
27. 1 cannabinoid receptor interactions: reciprocal inhibition of receptor signaling and neuritogenesis Br. J. Pharmacol. 148 2006 387 395 (Pubitemid 43882074)
28. 1 receptors form functional heteromeric complexes that mediate the motor effects of cannabinoids Neuropsychopharmacology 32 2007 2249 2259 (Pubitemid 47587686)
29. 1R heteromerization reveals a new mechanism for the pathogenic properties of angiotensin II EMBO J. 30 2011 2350 2363
30. 1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function J. Biol. Chem. 281 2006 38812 38824 (Pubitemid 46042008)
31. J. Chen, and H.S. Randeva Genomic organization of mouse orexin receptors: characterization of two novel tissue-specific splice variants Mol. Endocrinol. 18 2004 2790 2804 (Pubitemid 39482066)
32. C. Wang, Y. Pan, R. Zhang, B. Bai, J. Chen, and H.S. Randeva Heterodimerization of Mouse Orexin type 2 receptor variants and the effects on signal transduction Biochim. Biophys. Acta 1843 2013 652 663
33. Y. Zhang, A. Gilliam, R. Maitra, M.I. Damaj, J.M. Tajuba, H.H. Seltzman, and B.F. Thomas Synthesis and biological evaluation of bivalent ligands for the cannabinoid 1 receptor J. Med. Chem. 53 2010 7048 7060
34. 1) receptors are potent analgesics devoid of tolerance J. Med. Chem. 56 2013 5505 5513